妇科门诊患者人乳头瘤病毒感染情况及随访 分析
Analysis of Human Papillomavirus Infection in Gynecologic Outpatients and Follow Up
DOI: 10.12677/acm.2026.1651985, PDF,   
作者: 陈 瑜, 叶 芳*:广西医科大学基础医学院免疫学教研室,广西 南宁;丘丽华, 马 伟:柳州市人民医院医学检验科,广西 柳州
关键词: 人乳头瘤病毒单一感染高危型感染年龄随诊持续阳性Human Papillomavirus Monoinfection High-Risk Infection Age Follow Up Persistent Positivity
摘要: 目的:分析柳州市人民医院妇科门诊女性人乳头瘤病毒(HPV)感染率、病毒亚型分布特点以及阳性病例的随诊情况。方法:回顾性系统分析了2022年3月至2023年3月在该院妇科门诊接受HPV核酸检测的9910例门诊患者的数据。结果:HPV感染总检出率为23.83%,其中检出率位居前三的亚型依次为HPV52 (20.21%)、HPV58 (8.85%)和HPV16 (8.51%),感染模式以单一感染(17.98%)和高危型感染(16.62%)为主。年龄分层分析表明,不同年龄段感染率存在显著差异,65岁以上人群感染率最高(37.43%),15~25岁群体次之(37.12%),而36~45岁群体感染率最低(18.85%)。在随访研究中,高危型感染患者的复诊率最高(54.95%),其中46.52%的复诊病例仍保持阳性;中低危型感染患者的复诊率最低(51.24%),其持续阳性率也最低(37.2%);高危混合型感染的复诊率为52.09%,但其持续阳性率最高(63.58%);弱阳性病例的复诊率为47.87%,其中43.33%的复诊病例转为阳性。结论:HPV感染的主要亚型包括16型、52型和58型,其感染模式以单一亚型和高危型为主。针对15至45岁以及65岁以上人群,需强化对上述常见亚型的筛查。同时,对于高危型感染、多重感染、高危混合型感染以及弱阳性患者,应加强治疗干预、持续监测和长期随访管理。
Abstract: Objective: To analyze the status of human papillomavirus (HPV) infection, subtype distribution characteristics, and positive case recurrence among women attending the gynecology outpatient clinic of Liuzhou People’s Hospital. Methods: Retrospective systematic analysis of data from 9910 outpatients who underwent HPV nucleic acid testing at the hospital’s gynecology clinic from March 2022 to March 2023. Results: The overall infection rate was 23.83%, and the top three subtypes of infection rate from high to low were HPV52 (20.21%), HPV58 (8.85%), and HPV16 (8.51%), with single infection (17.98%) and high-risk type infection (16.62%) predominating; the difference of infection in each age group was statistically significant, with the highest rate in the group of >65 years old (37.43%), followed by the group of 15~25 years old (37.12%), and the group of 36~45 years old had the lowest rate of infection (18.85%); the high-risk type of infection had the highest rate of recurrence (54.95%), and 46.52% of the recurrence cases were consistently positive; the medium-low-risk type had the lowest rate of recurrence (51.24%), and the lowest number of recurrence cases were consistently positive (37.2%); and the rate of recurrence of high-risk mixed type was 52.09%, with the highest rate of sustained positivity in the retested cases (63.58%); the retesting rate of weakly positive cases was 47.87%, and 43.33% of the retested cases turned positive after retesting. Conclusion: The main subtypes of HPV infection include types 16, 52 and 58, and the pattern of infection is dominated by single subtypes and high-risk types. Screening for these common subtypes should be intensified for people aged 15~45 years and over 65 years. Meanwhile, for high-risk infections, multiple infections, high-risk mixed infections and weakly positive patients, therapeutic interventions, continuous monitoring and long-term follow up management should be strengthened.
文章引用:陈瑜, 丘丽华, 马伟, 叶芳. 妇科门诊患者人乳头瘤病毒感染情况及随访 分析[J]. 临床医学进展, 2026, 16(5): 1817-1824. https://doi.org/10.12677/acm.2026.1651985

参考文献

[1] de Villiers, E., Fauquet, C., Broker, T.R., Bernard, H. and Zur Hausen, H. (2004) Classification of Papillomaviruses. Virology, 324, 17-27. [Google Scholar] [CrossRef] [PubMed]
[2] 张仕华, 孙辉, 杜彦丹. 人乳头瘤病毒感染与生殖器病变关系的研究进展[J]. 中国医药导报, 2020, 17(4): 48-51.
[3] 米兰, 毕蕙. 人乳头瘤病毒所致感染的防控[J]. 中国实用妇科与产科杂志, 2024, 40(7): 687-692.
[4] Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. [Google Scholar] [CrossRef] [PubMed]
[5] 郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2024, 46(3): 221-231.
[6] 杨玉崟, 彭泱泱, 唐玲, 等. 云南省德宏州各民族子宫颈人乳头瘤病毒感染相关因素分析[J]. 中国实用妇科与产科杂志, 2023, 39(3): 350-352.
[7] 崔玉英, 郭妍珏, 李玲. 某院妇科门诊就诊患者人乳头瘤病毒感染状况分析[J]. 山西医药杂志, 2023, 52(15): 1171-1174.
[8] 詹望桃, 邹兴文, 夏闻婕, 等. 广州地区女性人乳头瘤病毒感染及宫颈细胞学检测结果分析[J]. 中国社会医学杂志, 2024, 41(4): 471-474.
[9] 章登政, 王亚, 姜琼, 等. 咸宁地区女性人乳头瘤病毒感染与子宫颈病变相关性分析[J]. 中国预防医学杂志, 2023, 24(8): 775-780.
[10] 许建霞, 张成思, 邓发滑, 等. 2020年贵州医科大学附属医院就诊女性人乳头瘤病毒感染特征分析[J]. 中国预防医学杂志, 2023, 24(12): 1328-1332.
[11] 吴坚, 张琳, 何妍谊, 等. 梧州地区2237例女性人乳头瘤病毒感染现状分析[J]. 中国计划生育和妇产科, 2024, 16(08): 81-84+94.
[12] 张睿, 周艳丽, 窦亚玲, 等. 人乳头瘤病毒和解脲脲原体、沙眼衣原体、淋病奈瑟菌的感染现状分析[J]. 中国医学科学院学报, 2018, 40(6): 817-821.
[13] 张涛红, 王丽莎, 安瑞芳, 等. 西安交通大学第一附属医院妇科门诊女性高危HPV感染情况[J]. 中国卫生统计, 2019, 36(1): 78-80.
[14] de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., et al. (2007) Worldwide Prevalence and Genotype Distribution of Cervical Human Papillomavirus DNA in Women with Normal Cytology: A Meta-Analysis. The Lancet Infectious Diseases, 7, 453-459. [Google Scholar] [CrossRef] [PubMed]
[15] 单玮, 张涛, 张铁军, 等. 我国女性人乳头瘤病毒(HPV)感染的流行病学现状[J]. 中华疾病控制杂志, 2017, 21(1): 89-93.
[16] 李玉佳, 祝佳佳, 王焰, 等. 贵阳市两城区女性人乳头瘤病毒的感染现状及基因型特点[J]. 贵州医科大学学报, 2024, 49(12): 1774-1779.
[17] 施文平, 徐嘉琳, 毛燕燕, 等. 医院就诊女性宫颈人乳头瘤病毒感染现状[J]. 中国公共卫生, 2015, 31(4): 434-437.
[18] 袁风菊, 徐培, 何小艳, 等. 德阳地区37799例宫颈人乳头瘤病毒流行病学调查分析[J]. 中国计划生育和妇产科, 2020, 12(3): 56-59.
[19] Lee, S.A., Kang, D., Seo, S.S., et al. (2003) Multiple HPV Infection in Cervical Cancer Screened by HPVDNAChip. Cancer Letters, 198, 187-192. [Google Scholar] [CrossRef] [PubMed]
[20] Dickson, E.L., Vogel, R.I., Geller, M.A. and Downs, L.S. (2014) Cervical Cytology and Multiple Type HPV Infection: A Study of 8182 Women Ages 31-65. Gynecologic Oncology, 133, 405-408. [Google Scholar] [CrossRef] [PubMed]
[21] Bekkers, R.L.M., Massuger, L.F.A.G., Bulten, J. and Melchers, W.J.G. (2004) Epidemiological and Clinical Aspects of Human Papillomavirus Detection in the Prevention of Cervical Cancer. Reviews in Medical Virology, 14, 95-105. [Google Scholar] [CrossRef] [PubMed]
[22] Bachtiary, B., Obermair, A., Dreier, B., Birner, P., Breitenecker, G., Knocke, T., et al. (2002) Impact of Multiple HPV Infection on Response to Treatment and Survival in Patients Receiving Radical Radiotherapy for Cervical Cancer. International Journal of Cancer, 102, 237-243. [Google Scholar] [CrossRef] [PubMed]
[23] Senapati, R., Nayak, B., Kar, S.K. and Dwibedi, B. (2017) HPV Genotypes Co-Infections Associated with Cervical Carcinoma: Special Focus on Phylogenetically Related and Non-Vaccine Targeted Genotypes. PLOS ONE, 12, e0187844. [Google Scholar] [CrossRef] [PubMed]
[24] Gallegos-Bolaños, J., Rivera-Domínguez, J.A., Presno-Bernal, J.M. and Cervantes-Villagrana, R.D. (2017) High Prevalence of Co-Infection between Human Papillomavirus (HPV) 51 and 52 in Mexican Population. BMC Cancer, 17, Article No. 531. [Google Scholar] [CrossRef] [PubMed]
[25] Stanley, M. (2006) Immune Responses to Human Papillomavirus. Vaccine, 24, S16-S22. [Google Scholar] [CrossRef] [PubMed]